FLAG-Ida Regimen as Bridge Therapy to Allotransplantation in Refractory/Relapsed Acute Myeloid Leukemia Patients-Reference-Cited by-同舟云学术

FLAG-Ida Regimen as Bridge Therapy to Allotransplantation in Refractory/Relapsed Acute Myeloid Leukemia Patients

Published:2017-11 Issue:11 Volume:17 Page:767-773
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Delia Mario,Pastore Domenico,Carluccio Paola,Pasciolla Crescenza,Ricco Alessandra,Rossi Antonella Russo,Casieri Paola,Mestice Anna,Albano Francesco^ORCID,Specchia Giorgina

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference36 articles.

1. Genomic classification and prognosis in acute myeloid leukemia;Papaemmanuil;N Engl J Med,2016

2. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia;Cheson;J Clin Oncol,2003

3. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet;Dohner;Blood,2010

4. Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy;Othus;Biol Blood Marrow Transplant,2015

5. A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia;Estey;Blood,1996

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FLAG-Ida’ya Karşı FLAG-Dauno: Relaps/Refrakter Akut Lösemi Olgularında Bursa Uludağ Üniversitesi Deneyimi;Uludağ Üniversitesi Tıp Fakültesi Dergisi;2024-05-17

2. Long term follow-up of refractory/relapsed acute myeloid leukemia patients treated with the FLAG-Ida regimen as bridge therapy to allotransplantation: 10-year results from a single centre experience;Leukemia Research;2023-06

3. Re-induction therapy in patients with acute myeloid leukemia not in complete remission after the first course of treatment;Annals of Hematology;2023-01-12

4. Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation;Bone Marrow Transplantation;2021-11-13

5. Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients;Leukemia Research;2021-02